Allianz Asset Management GmbH - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$425,432
-16.9%
7,1000.0%0.00%0.0%
Q2 2023$511,910
+34.0%
7,100
+183.4%
0.00%
Q1 2021$382,000
-92.8%
2,505
-93.6%
0.00%
-100.0%
Q4 2018$5,327,000
+6.1%
39,256
+114.7%
0.01%
+20.0%
Q3 2018$5,019,000
+56.0%
18,285
+17.8%
0.01%
+66.7%
Q2 2018$3,217,000
-29.7%
15,527
-43.9%
0.00%
-25.0%
Q1 2018$4,575,000
-13.2%
27,702
-28.0%
0.00%0.0%
Q4 2017$5,270,000
-30.0%
38,488
-30.4%
0.00%
-42.9%
Q3 2017$7,531,000
-9.4%
55,317
-19.2%
0.01%
-12.5%
Q2 2017$8,310,000
+22.3%
68,450
+6.6%
0.01%
+14.3%
Q1 2017$6,796,000
-14.0%
64,214
-17.4%
0.01%0.0%
Q4 2016$7,900,000
-40.6%
77,741
-40.3%
0.01%
-46.2%
Q3 2016$13,290,000
-12.9%
130,218
+1.7%
0.01%
-18.8%
Q2 2016$15,265,000
-45.2%
127,991
-50.8%
0.02%
-50.0%
Q1 2016$27,845,000
+1.6%
260,016
+2.9%
0.03%
+3.2%
Q4 2015$27,401,000
+45.4%
252,731
+14.8%
0.03%
+40.9%
Q3 2015$18,848,000
-29.4%
220,060
-16.8%
0.02%
-24.1%
Q2 2015$26,684,000
-3.6%
264,459
-26.3%
0.03%
-9.4%
Q1 2015$27,678,000
+26.9%
358,938
-12.4%
0.03%
+33.3%
Q4 2014$21,805,000
+16.9%
409,781
+2.7%
0.02%
+9.1%
Q3 2014$18,648,000
+7.7%
399,083
+43.6%
0.02%0.0%
Q2 2014$17,314,000
-7.3%
277,963
-0.7%
0.02%0.0%
Q1 2014$18,684,000
+47.6%
279,831
+16.2%
0.02%
+37.5%
Q4 2013$12,662,000
+64.5%
240,722
+35.4%
0.02%
+60.0%
Q3 2013$7,695,000
+21.0%
177,806
+4.5%
0.01%
+11.1%
Q2 2013$6,361,000170,1000.01%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Knott David M Jr 115,000$7,6822.90%
VILLERE ST DENIS J & CO LLC 483,347$32,2872.52%
Monarch Partners Asset Management LLC 62,327$4,163,4441.23%
Chicago Capital, LLC 319,054$21,312,8201.18%
RICE HALL JAMES & ASSOCIATES, LLC 285,634$19,080,3511.09%
Stephens Investment Management Group LLC 454,416$30,713,9770.56%
Smith, Graham & Co., Investment Advisors, LP 65,372$4,366,8500.53%
WOODSTOCK CORP 55,014$3,674,9350.49%
Court Place Advisors, LLC 15,533$1,037,6050.38%
ISTHMUS PARTNERS, LLC 19,830$1,324,6440.20%
View complete list of LIGAND PHARMACEUTICALS INC shareholders